Transhumanism

From PRIMO.ai
Jump to navigation Jump to search


YouTube ... Quora ...Google search ...Google News ...Bing News


Transhumanism is a philosophical and intellectual movement that explores how science and technology might expand human physical, cognitive, biological, and psychological capabilities beyond their present limitations. Its central proposition is that human abilities need not remain restricted to those produced by biological evolution: through deliberate technological development, people may be able to restore lost functions, prevent disease, extend healthy life, improve cognition, and eventually acquire capabilities that ordinary human biology does not allow. The movement draws on artificial intelligence, Neuroscience, biotechnology, genetic engineering, cybernetics, regenerative medicine, robotics, and computer science.

Conventional medicine generally aims to return a patient to a typical human baseline, while transhumanism asks whether that baseline should be treated as a ceiling. Some transhumanist proposals involve technologies already used in medicine, such as cochlear implants, advanced prosthetics, and selected gene therapies. Other proposals, including radical lifespan extension, direct integration of human cognition with AI, and digital continuation of consciousness, remain experimental or speculative. Transhumanism is therefore best understood as a combination of four things:

  • A philosophical position: Humans should be able to investigate and potentially transcend biological limitations.
  • A technological research direction: Science and engineering may provide increasingly powerful ways to modify or augment human capabilities.
  • An ethical debate: Society must determine which enhancements are desirable, who should have access to them, and how autonomy, identity, dignity, and safety should be protected.
  • A long-term vision: Technological change could eventually produce forms of human or posthuman existence substantially different from those known today.

The movement does not represent a single scientific theory or a universally agreed political program, and its supporters differ over the appropriate technologies, risks, social policies, and ultimate objectives. Its critics are just as varied, ranging from bioconservative philosophers who defend the value of human limits to scholars who argue that transhumanism repackages older eugenic ideas. Throughout this page, established medical achievements are distinguished from preliminary results and from long-range speculation, because public discussion of transhumanism often blurs the three.


Humanity's biological limitations may not be permanent. Science and technology could allow people to repair, augment, and transform their bodies and minds, potentially creating new forms of human existence. The central challenge is not simply whether we can develop these capabilities, but whether we can use them to improve human flourishing while preserving autonomy, dignity, identity, and meaningful relationships.


Historical Origins and Major Thinkers

The modern transhumanist movement developed from earlier ideas about human progress, evolution, and the application of science to human improvement. Evolutionary biologist Julian Huxley popularized the term transhumanism in the 1950s, most influentially in a 1957 essay, describing the possibility that humanity could deliberately move beyond its existing condition. Huxley also served as president of Britain's Eugenics Society, a link that critics of the movement still emphasize. An organized movement took shape from the late 1980s onward through extropian writing, the founding of the World Transhumanist Association by Nick Bostrom and David Pearce in 1998 (renamed Humanity+ in 2008), and the Transhumanist Declaration published the same year. Key figures include:

  • FM-2030, the futurist and philosopher formerly known as Fereidoun M. Esfandiary, developed influential ideas about technological progress, human identity, and the transition beyond conventional biological and social limitations, set out in his 1989 book Are You a Transhuman?
  • Max More helped formalize modern transhumanist philosophy through his writing on extropianism, technological progress, individual choice, and self-transformation.
  • Natasha Vita-More contributed ideas concerning human enhancement, future bodies, design, and the ethical and cultural implications of emerging technologies.
  • Nick Bostrom examined human enhancement, existential risk, artificial superintelligence, and the philosophical implications of posthuman possibilities, including in Superintelligence (2014). The Future of Humanity Institute he founded at Oxford closed in April 2024.
  • Ray Kurzweil popularized predictions about accelerating technological progress, artificial intelligence, longevity, and increasingly close relationships between biological and machine intelligence, most recently in The Singularity Is Nearer (2024).
  • Anders Sandberg has explored cognitive enhancement, whole-brain emulation, technological risk, and the long-term consequences of human modification; with Bostrom he wrote the 2008 report Whole Brain Emulation: A Roadmap.
  • Ben Goertzel, a former chair of Humanity+, has promoted artificial general intelligence as a route to radical human transformation and founded SingularityNET.
  • Susan Schneider has investigated consciousness, personal identity, artificial intelligence, and whether incorporating AI into the brain could fundamentally change or end the individual's conscious existence, notably in Artificial You (2019).

Critics have been equally influential. Political scientist Francis Fukuyama called transhumanism one of the world's most dangerous ideas in 2004, philosopher Michael Sandel argued in The Case Against Perfection (2007) that the drive to engineer ourselves threatens an appreciation of life as a gift, and in 2024 Timnit Gebru and Émile P. Torres grouped transhumanism with related movements under the label "TESCREAL" and traced the bundle to twentieth-century eugenics. These thinkers, supporters and critics alike, have contributed different perspectives, and their predictions and philosophical arguments should not be mistaken for established scientific findings.

Therapy, Enhancement, and Posthumanism

An important distinction is the difference between restoring an impaired human capability and extending that capability beyond conventional human functioning. Several related terms are used, sometimes inconsistently, in this debate:

  • Therapy seeks to prevent or treat disease or restore a function.
  • Enhancement seeks to increase a capability beyond an established baseline.
  • Transhuman generally describes a human whose capabilities or condition have been significantly altered through technology, or a proposed transitional condition between present-day humans and posthumans.
  • Posthuman is a philosophical term for a possible future being whose capabilities or mode of existence differ so extensively from current humans that ordinary human categories may no longer adequately describe it.
  • Posthumanism is also a broader philosophical and cultural field that questions human exceptionalism and traditional definitions of the human. It overlaps with transhumanism but does not necessarily advocate technological enhancement.

The therapy-enhancement distinction is not always straightforward. A retinal implant that restores limited sight is primarily therapeutic, while a hypothetical implant providing infrared vision beyond ordinary human capabilities would be an enhancement. Similarly, gene editing used to treat a serious inherited disease is different from attempting to increase intelligence or other complex traits in otherwise healthy people. Vaccination shows how blurry the line can be: it strengthens a healthy immune system beyond its unaided state, yet few people regard it as a transhumanist project. The ethical and regulatory questions may therefore differ substantially even when the underlying technology is the same.

Current State of the Field

The table below summarizes where the main enhancement technologies stood in October 2026, alongside the more ambitious possibilities that transhumanists associate with them. Several rows changed substantially between 2024 and 2026.

Technology Current status Long-term transhumanist possibility
Bionic prosthetics and cochlear implants Established medical applications, with continuing improvements Expanded physical and sensory capabilities
Brain-computer interfaces Investigational implants in clinical trials (Neuralink reported 21 participants in January 2026; Paradromics implanted its first trial participant in June 2026); a cortical electrode array cleared by the FDA for implantation of up to 30 days; established therapeutic neurotechnologies such as deep brain stimulation Direct interaction between neural systems and computational tools
Somatic genome editing Approved treatments for specific diseases (Casgevy, extended to children aged 2 and older in July 2026) and individualized experimental applications Precise modification of selected biological characteristics
Heritable (germline) genome editing Not permitted for clinical use in many countries; startups began preclinical embryo-editing research in 2025 Inherited genetic changes passed to future generations
AI cognitive assistance Widely available software More integrated human-AI decision-making and cognition
Regenerative medicine Established applications alongside experimental cell and tissue therapies More extensive biological repair and organ replacement
Biological aging interventions Active research with limited human evidence for experimental geroprotective treatments; a lifespan-extension drug for dogs is advancing through FDA veterinary review Longer healthspan and possibly extended lifespan
Whole-brain emulation Hypothetical for humans; the whole fruit-fly brain has been simulated from its connectome, and an embodied fly emulation was demonstrated in 2026 without peer review Computational reconstruction of a person's neural processes
Mind uploading or consciousness transfer No demonstrated capability Proposed continuation of a person's mind in a nonbiological system
AI personality replicas Commercially available in varying forms Interactive digital legacy and increasingly personalized avatars

The existence of a technology does not establish that its most ambitious proposed applications are achievable. A brain-computer interface that restores typing for a person with paralysis says little about whether healthy people could someday download knowledge, and a gene therapy for one inherited disease says little about engineering intelligence. Each row should therefore be read as a description of present capability, with the right-hand column representing hopes rather than forecasts.

The Mechanism

Transhumanism has no single mechanism because it encompasses several fundamentally different technological approaches, which can be organized according to the human capabilities they seek to change and the level at which they operate. Some act on molecules and cells, some connect the nervous system to machines, and some leave the body untouched and augment cognition from the outside. What they share is a dependence on measurement, intervention, and feedback, a theme that closes this section.

Biological Enhancement

Biological enhancement modifies living systems through medical treatment, genetic intervention, cellular engineering, or biological replacement. Potential mechanisms include:

  • Altering gene expression.
  • Correcting disease-causing DNA variants.
  • Replacing damaged or dysfunctional cells.
  • Regenerating tissues.
  • Modulating biochemical pathways.
  • Improving or restoring organ function.
  • Intervening in cellular processes associated with aging.

For example, somatic gene editing can modify selected cells to address an inherited disorder, and the intended benefit depends on the condition, the targeted cells, the delivery mechanism, and the downstream biological consequences. Changing a gene associated with a complex characteristic does not guarantee a predictable improvement in that characteristic, because most traits, including intelligence, involve hundreds to thousands of genetic variants of small effect interacting with development and environment. This is why edits that correct a single disease-causing gene have reached the clinic, while proposals to engineer complex traits remain speculative.

Cybernetic Enhancement

Cybernetics, a field named by mathematician Norbert Wiener in 1948, concerns communication and control in systems involving feedback. A cybernetic prosthesis combines sensors, computing, mechanical or electrical actuators, and feedback mechanisms, and an advanced artificial hand might work through the following sequence:

  1. Sensors detect signals associated with the user's intended movement, often electrical activity from remaining muscles.
  2. A processor interprets the signals using signal processing and pattern recognition.
  3. The controller determines the movement to perform.
  4. Motors or other actuators move the prosthetic fingers.
  5. Sensors monitor force, position, or contact.
  6. Feedback helps the user or controller adjust the movement.

Some research systems deliver sensory information through stimulation of peripheral nerves or the nervous system, helping users perceive aspects of contact or force rather than relying exclusively on visual feedback. The main challenge is developing a reliable connection between the user's intent, the machine's actions, and the user's perception of the result. When that loop works well, users report that a prosthesis begins to feel like part of the body rather than a tool, an effect researchers call embodiment.

Neural Enhancement Through Brain-Computer Interfaces

A brain-computer interface (BCI) records neural activity and converts selected signal patterns into computer-readable instructions, and it can also form part of a system that delivers information to the nervous system through stimulation. Brain-computer interfaces can be:

  • Noninvasive: Using sensors placed outside the skull, such as electroencephalography (EEG), including consumer headsets and other wearables.
  • Partially invasive: Using devices positioned inside the skull or within blood vessels but not penetrating brain tissue, such as thin-film electrode arrays on the brain surface or stent-mounted electrodes threaded through a vein.
  • Invasive: Using implanted electrodes that record activity directly from neural tissue.

Neural signals are noisy, variable, and dependent on context, so machine-learning systems often help interpret them by identifying patterns associated with attempted movements, intended speech, or other defined tasks. For example, a person with paralysis may attempt to speak while neural sensors record activity associated with speech production, and a trained decoder can convert these patterns into text or synthesized speech. Current research demonstrates that carefully calibrated systems can restore selected communication abilities. It does not demonstrate unrestricted mind reading or the ability to transfer an individual's entire mental experience into a computer.

Artificial Intelligence as Cognitive Augmentation

AI already enhances many human activities without requiring biological modification. Examples include:

  • Supporting memory and information retrieval.
  • Translating language.
  • Summarizing complex material.
  • Assisting with scientific analysis.
  • Creating images, audio, and written content with generative AI.
  • Identifying patterns in data.
  • Supporting planning and problem-solving.
  • Automating selected tasks through Agents/Assistants.

This represents external cognitive augmentation: the technology supplements the user's capabilities through software rather than altering the brain directly. The idea has deep roots, from writing and calculators to smartphones, and philosophers Andy Clark and David Chalmers argued in their 1998 "extended mind" thesis that tools tightly coupled to our thinking can count as part of cognition itself. Large language models have made this kind of augmentation conversational and nearly ubiquitous, which is why many observers see everyday AI use, rather than implants, as the most widespread form of human enhancement today.

More ambitious proposals involve integrating AI with neural interfaces, a goal sometimes described as human-AI symbiosis. A hypothetical system might combine neural signals, context-aware computing, memory retrieval, and sensory feedback; Neuralink and Merge Labs, a startup co-founded by OpenAI chief executive Sam Altman that raised $252 million in January 2026 to pursue noninvasive, ultrasound-based interfaces, both describe this kind of integration as a long-term aim. The difficulty is not merely creating a faster computer. Researchers must determine which neural representations can be interpreted, how information can be delivered meaningfully to the brain, and whether users can maintain control over the resulting system.

Digital Identity and Personality Simulation

Digital identity systems attempt to represent selected characteristics of a person using stored information. Potential inputs include:

  • Written messages.
  • Photographs.
  • Video recordings.
  • Voice recordings.
  • Biographical interviews.
  • Personal documents.
  • Recollections from family members.
  • Recorded preferences and opinions.
  • Interaction histories.

An AI system may retrieve relevant recorded information, an approach related to retrieval-augmented generation, or generate responses based on patterns learned from that material. The resulting avatar can appear familiar because it resembles the person's voice, language, appearance, or conversational style. However, reconstructing observable behavior is not the same as preserving consciousness. A digital avatar may provide a convincing imitation of a person without sharing that person's subjective experience, knowledge, values, or personal identity.

The Importance of Feedback and Adaptation

Most practical enhancement technologies depend on feedback: the system measures a physical or biological signal, calculates a response, applies an intervention, and evaluates the consequences. This general pattern occurs in robotic prosthetics, brain stimulation, adaptive medical devices, and AI-assisted decision-making. In February 2025, for example, the FDA approved Medtronic's BrainSense adaptive deep brain stimulation for Parkinson's disease, which adjusts stimulation automatically in response to the patient's own brain signals instead of running at fixed settings. Reliable enhancement requires the system to remain calibrated as the user's body, environment, and objectives change.

Human adaptation is equally important. A device that performs well in a laboratory may require extensive practice before becoming useful in everyday life, and neural decoders often need recalibration as recorded signals drift over days and weeks. In the most successful systems, the person and the machine learn together, a process researchers call co-adaptation.

The Physics

The scientific foundations of human enhancement involve molecular biology, electrophysiology, mechanics, information processing, and thermodynamics. Different technologies operate at different physical scales, from edits to single DNA letters a fraction of a nanometer across to powered limbs that must carry body weight. Understanding these constraints explains why some enhancements have arrived quickly while others remain distant.

Molecular Biology and Genome Editing

DNA stores genetic information through sequences of nucleotide bases, and genes and regulatory elements in the genome influence the production of RNA and proteins, which participate in cellular structure and function. CRISPR-based systems use programmable molecular components, typically a guide RNA that directs a Cas enzyme, to recognize selected DNA sequences. Depending on the system, genome editing may involve:

  • Cutting DNA at targeted locations.
  • Disabling a gene.
  • Correcting or changing selected DNA bases.
  • Modifying gene regulation.
  • Introducing a sequence through a suitable repair or delivery mechanism.

Base editing can alter certain nucleotide bases without requiring the same type of double-strand DNA break used by conventional CRISPR-Cas9 editing, and prime editing offers another approach to making selected sequence changes. These technologies require accurate molecular targeting, delivery to appropriate cells, and evaluation of unintended effects. A genetic modification may alter protein production or cellular behavior, but biological consequences often extend beyond a single molecular interaction, and delivery remains a bottleneck: lipid nanoparticles reach the liver efficiently, while the brain and muscles are far harder to target. Safety signals still arise in late-stage trials; in October 2025, the FDA placed two phase 3 trials of Intellia's in vivo CRISPR therapy on hold after a participant developed severe liver injury, before allowing them to resume in early 2026 with enhanced liver monitoring.

Somatic editing changes cells in the treated individual without intending to transmit those changes to descendants, whereas germline editing changes reproductive cells or embryos in ways that may affect future generations. These approaches raise different scientific, regulatory, and ethical questions. The births of gene-edited children in China in 2018 and 2019, for which researcher He Jiankui was later imprisoned, remain the only known clinical use of heritable editing and were condemned by scientists worldwide.

Neural Electricity and Signal Decoding

Neurons communicate through electrical and chemical processes. Changes in membrane voltage produce electrical signals called action potentials, brief spikes of roughly 100 millivolts lasting about a millisecond, and information in neural systems depends on the timing, distribution, and interactions of activity across many neurons. Brain-computer interfaces use measurements of this activity as inputs to computational models. A simplified BCI processing chain is:

Neural activity → signal acquisition → filtering → feature extraction → decoding → computer or device output

Signal acquisition may involve microelectrodes, cortical surface electrodes, EEG sensors, or other techniques, and the recorded signals are incomplete measurements of the underlying neural activity. Decoders therefore estimate intended actions from statistical relationships identified during training, often using deep learning models such as recurrent neural networks. Greater recording bandwidth or more electrodes can provide additional information, but does not guarantee accurate decoding; the quality of the model, anatomical placement, signal stability, and training procedure all matter. Scale also matters: implants now in human trials record from a few hundred to about a thousand electrode sites, while the human brain contains about 86 billion neurons, so even the best devices sample a tiny fraction of its activity.

Neural Stimulation and Bidirectional Interfaces

Some interfaces deliver signals into the nervous system through controlled electrical stimulation; examples include cochlear implants, deep brain stimulation, and selected sensory-feedback prosthetics. Stimulation alters electrical activity in targeted tissue, and the resulting physiological effect depends on electrode location, current distribution, timing, pulse characteristics, and the surrounding neural circuits. Optogenetics offers a more selective alternative: genes for light-sensitive ion channels are delivered to chosen cells so that light can switch them on or off, and its pioneers Karl Deisseroth, Peter Hegemann, and Georg Nagel received the 2026 Nobel Prize in Physiology or Medicine. A bidirectional interface combines recording and stimulation. Such systems may eventually support more natural interactions between users and external devices, but stimulation must be carefully constrained to avoid unintended effects.

Mechanics and Bionic Systems

Bionic limbs and powered exoskeletons must obey the same mechanical principles as other physical machines, with force, torque, momentum, and energy determining movement. An actuator must generate sufficient force to move a load, while the controller must maintain balance, stability, and safe contact with the environment. Human movement also depends on flexible tissues, muscles, joints, sensory feedback, and learned coordination, and replicating these interactions mechanically is difficult. An artificial limb may outperform a biological limb on one specific engineering measure while remaining inferior in dexterity, adaptability, sensation, or energy efficiency.

Thermodynamics and Biological Aging

Living systems continuously use energy to maintain structure and function, holding themselves far from thermodynamic equilibrium. Cells must repair molecular damage, regulate proteins, maintain membranes, reproduce or replace cellular components, and respond to environmental stress. Aging involves interacting biological processes rather than one universally accepted mechanism, and researchers commonly organize them into "hallmarks of aging," a framework first proposed in 2013 and expanded in 2023. Research areas include:

  • Genomic instability.
  • Telomere-related changes.
  • Epigenetic alterations.
  • Loss of protein homeostasis.
  • Disabled autophagy, the cell's system for recycling damaged components.
  • Mitochondrial dysfunction.
  • Cellular senescence.
  • Altered nutrient sensing.
  • Stem-cell exhaustion.
  • Chronic inflammation.
  • Changes in intercellular communication.
  • Dysbiosis, or age-related changes in the microbiome.

Understanding these processes may enable interventions that preserve function or reduce the burden of age-associated disease. However, the thermodynamics of living systems does not establish a fixed maximum human lifespan, nor does it imply that eliminating one aging mechanism would produce indefinite survival. The longest verified human life, that of Jeanne Calment, ended at 122 years in 1997, and demographers continue to debate whether a practical limit exists. All proposed interventions must be tested for benefits, tradeoffs, and long-term safety.

Information, Memory, and Consciousness

Memory is not simply a collection of digital facts stored in the brain. Neuroscientific evidence links memory to distributed neural activity, synaptic changes, cellular processes, and interactions between brain systems. Reconstructing a person's memories would therefore require much more than collecting their recorded conversations; it would require understanding which biological states encode relevant information and how those states contribute to ongoing cognitive processes. The scale is daunting: a 2024 map of a single cubic millimeter of human cortex contained about 57,000 cells and 150 million synapses and required 1.4 petabytes of data, yet that sample is roughly one-millionth of a human brain.

Even a highly detailed reconstruction would leave a philosophical question unresolved: would the resulting system be the original conscious individual, or a new system reproducing some of that individual's characteristics? Functionalist theories hold that the right pattern of information processing would be enough for consciousness, while biological and physical theories, including quantum proposals such as Orch-OR, tie consciousness to specific features of living brains. There is no established scientific test demonstrating that subjective personal identity can be transferred from a biological brain to a computer.

Why This Matters

Transhumanism raises practical questions about medicine, disability, aging, autonomy, intelligence, and the future of human society. Even people who doubt that radical enhancement will ever arrive meet these questions now, because many of the underlying technologies are already in clinics, phones, and courtrooms. The subsections below move from the most concrete benefits to the most contested questions.

Restoring Human Capabilities

The most immediate benefits arise from therapeutic applications. Neuroprosthetics, sensory implants, advanced prosthetic limbs, and gene therapies can improve the lives of people with significant medical conditions; recent examples include speech neuroprostheses for people with paralysis, a CRISPR-based therapy for sickle cell disease, and a retinal implant that restored some reading ability in age-related macular degeneration. These applications demonstrate that technology can modify the practical limits of human functioning, and they do not require assuming that more radical transhumanist predictions will occur.

Extending Healthy Life

Research into aging may improve the prevention and treatment of age-associated disease, because aging is the largest single risk factor for most chronic illnesses in healthcare systems worldwide. The scientifically meaningful objective is often healthspan, the period of life spent in relatively good health, rather than lifespan alone. Increasing survival while leaving people with additional years of severe disability would not necessarily achieve the broader goal of human flourishing.

Expanding Cognitive Capability

AI can increase access to knowledge and support tasks that exceed unaided human memory or calculation. However, improved access to information is not equivalent to improved judgment, and AI systems can produce errors, misleading answers, and recommendations that do not reflect a user's values. People also tend to over-trust confident automated output, a tendency known as automation bias. Effective cognitive augmentation therefore requires independent judgment, transparency, and meaningful user control.

Personal Autonomy and Human Rights

Enhancement technologies can influence how people think, move, communicate, and participate in society. This raises questions about:

  • Informed consent.
  • Control of neural and biological data.
  • Freedom to refuse enhancement.
  • Access to essential medical treatment.
  • Fairness in education and employment.
  • Privacy and cybersecurity.
  • Disability rights.
  • Long-term device support.
  • Commercial control over implanted or biologically integrated systems.

The ability to enhance a capability does not automatically justify requiring people to use the enhancement. The risk of abandonment is also real: after Second Sight Medical Products wound down its Argus II retinal implant around 2020, many of the more than 350 people who had received it were left with little technical support for devices inside their bodies. Long-term maintenance, repair, and data access therefore belong in any serious discussion of implanted enhancement.

Identity and the Meaning of Being Human

Human identity includes biological continuity, memory, relationships, behavior, personal history, and subjective experience, and different philosophical and religious traditions assign different importance to these features. As technologies increasingly alter bodies and cognitive processes, some familiar definitions of human identity may become less useful. The deeper question is whether enhanced capabilities necessarily improve human well-being, relationships, and the conditions under which life has Meaning. Technological capability and meaningful human experience are related but distinct concerns.

Transhumanism Era

The phrase transhumanism era usually refers to a proposed period in which human enhancement technologies become increasingly powerful and widespread. It is not a formally defined historical epoch, and there is no scientific consensus identifying a date when such an era began or will begin. Some aspects of enhancement are already routine, others are at the clinical research stage, and the most ambitious predictions remain uncertain.

A Possible Progression

One way to picture the debate is as a series of increasingly ambitious levels of capability. Each level rests on a very different evidence base, from routine clinical use to pure speculation.

Stage Characteristics Evidence and limitations
Therapeutic augmentation Prosthetics, implants, assistive technologies, and disease-targeted genetic treatments Established for selected conditions
Increasingly personalized augmentation More individualized neural interfaces, AI assistance, and regenerative interventions Emerging through research and clinical development
Integrated human-machine systems More continuous interaction between biological cognition and external computing Partially demonstrated in specialized interfaces; broad cognitive integration remains speculative
Radical biological enhancement Major expansion of human cognitive, physical, or lifespan capabilities Hypothetical beyond selected therapeutic achievements
Posthuman or digital existence Proposed forms of existence no longer dependent on ordinary biological human bodies Philosophical and speculative

This table represents possible levels of technological capability, not an inevitable progression. There is no evidence that one stage must lead to the next, and different technologies may advance at very different rates or stall entirely. Some transhumanists expect the later stages within decades, while most neuroscientists and biologists regard them as far more distant, if achievable at all.

Different Visions of the Future

People who agree on the facts about these technologies often disagree sharply about what should be done with them. The main positions include:

  • Medical humanism emphasizes using technology to reduce suffering, restore functioning, and expand healthcare.
  • Technological transhumanism emphasizes voluntary enhancement and the expansion of human capability.
  • Democratic transhumanism places greater emphasis on access, rights, and preventing enhancements from creating entrenched social inequality.
  • Bioconservative criticism questions whether deliberate enhancement might undermine dignity, social institutions, or valuable aspects of human vulnerability.
  • Religious and spiritual perspectives vary widely. Some regard technological enhancement as compatible with human responsibility, while others question whether radical modification conflicts with particular conceptions of human nature.
  • Posthumanist criticism challenges the assumption that increasingly powerful human individuals should remain the primary goal of technological development.
  • Critiques of techno-utopianism, such as Gebru and Torres's "TESCREAL" analysis, argue that transhumanism and allied movements inherit the logic of eugenics and serve the interests of technology elites; defenders respond that voluntary, individual choices differ fundamentally from state-imposed eugenics.

These perspectives reflect real disagreements about desirable outcomes rather than merely differing predictions about future technology. Many people hold elements of several positions at once, for example welcoming gene therapy for disease while opposing heritable enhancement. Recognizing whether a given dispute is factual or moral usually makes the debate more productive.

Risks of Unequal Enhancement

If advanced enhancements become expensive, uneven access could affect education, employment, healthcare, or economic opportunity. A technology that improves a scarce or economically valuable capability could create pressure on others to adopt it; even an officially voluntary cognitive enhancement might become functionally compulsory in a highly competitive profession. These possibilities raise questions about affordability, regulation, workplace protections, and the right to remain unenhanced. UNESCO's 2025 neurotechnology recommendation addresses one version of the problem directly, calling for neurotechnology at work to be strictly voluntary, with clear opt-in and opt-out procedures.

Transhumanism and the Singularity

Some transhumanist thinkers associate human enhancement with a future technological singularity, a proposed period of unusually rapid and transformative technological change. The concept is often associated with Vernor Vinge, whose 1993 essay popularized the term, and Ray Kurzweil, who has long predicted a singularity around 2045. One speculative scenario involves increasingly capable AI accelerating scientific and technological development, including further AI improvement and human augmentation. However, the singularity is not an established scientific prediction, and there is no agreed definition, timeline, or validated model demonstrating that technological progress must produce such an event. Human enhancement and artificial superintelligence are also separable questions, so progress in one does not guarantee progress in the other.

Longevity and Life Extension

One of the most influential transhumanist objectives is extending healthy human life. Longevity research investigates why organisms age, how aging contributes to disease, and whether interventions can maintain physiological function. The field has attracted unusually large private investment for such early-stage science, including the launch of Altos Labs with $3 billion in 2022, which has raised both hopes and concerns about hype.

Healthspan Versus Lifespan

Lifespan is the duration of life, while healthspan refers to the portion of life spent in relatively good health and with functional independence. A useful intervention should be evaluated in terms of meaningful outcomes, such as mobility, cognitive function, disease incidence, disability, and survival. A change in a laboratory biomarker is not sufficient proof of longer life.

Major Research Directions

No single strategy dominates the field. Researchers are pursuing several partly overlapping approaches:

  • Cellular senescence: Researchers study whether selectively targeting senescent cells, using drugs called senolytics, can improve tissue function or reduce disease burden.
  • mTOR signaling: Drugs affecting nutrient-sensing pathways, including rapamycin and related compounds, have demonstrated effects on lifespan in several model organisms, including mice treated late in life.
  • Metabolic interventions: Researchers investigate calorie restriction, dietary patterns, metabolic signaling, and compounds such as metformin.
  • Epigenetic reprogramming: Experimental methods attempt to change aspects of cellular state associated with aging, for example by briefly activating the "Yamanaka" factors used to make stem cells. These techniques must address serious questions involving cell identity, abnormal growth, and long-term safety.
  • Stem-cell and regenerative treatments: These approaches seek to repair or replace damaged cells and tissues.
  • Immune-system aging: Investigators study how age-related changes in immune function contribute to infection risk, inflammation, and disease.
  • Biological age measurements: Researchers use molecular and physiological indicators, such as DNA methylation "clocks," to estimate aspects of biological aging.
  • Veterinary longevity drugs: Companion dogs share human environments and age faster, making them a test case. The company Loyal's LOY-002, a daily pill for senior dogs, has had both the effectiveness section (February 2025) and the safety section (announced January 2026) of its FDA conditional-approval application accepted, while a four-year efficacy trial in more than 1,000 dogs continues.

What Has Actually Been Demonstrated?

Several interventions extend lifespan or improve selected age-related measures in laboratory organisms, and these results establish that aspects of aging biology can be modified. They do not establish that the same interventions safely extend maximum human lifespan. A 2025 appraisal of 667 preclinical studies in the DrugAge database found that randomization and blinding were rarely reported and that only about a third of lifespan effects seen in non-mammals carried over to mammals, a warning about how much weight animal results can bear.

In humans, evidence varies by intervention and clinical objective, and treatments shown to improve outcomes for particular diseases should not automatically be described as general anti-aging therapies. As of October 2026, there is no clinically established treatment that makes humans biologically immortal or reliably produces radical lifespan extension. There is also no universally validated molecular biological-age measure that can substitute for long-term clinical outcomes across all interventions.

Brain-Computer Interfaces and Connecting Brains

Brain-computer interfaces represent one of the most concrete intersections between neuroscience, computing, and human augmentation. Their principal clinical applications include restoring communication and enabling control of external devices, and research also explores sensory restoration, motor rehabilitation, and therapeutic stimulation. Since 2024 the field has moved from academic demonstrations toward company-run clinical trials, a shift described under Recent Developments.

Brain-to-Computer Communication

A brain-to-computer interface typically converts neural activity into control signals. Applications demonstrated in research include:

  • Selecting letters or words.
  • Controlling computer cursors.
  • Operating robotic devices.
  • Producing synthesized speech.
  • Interacting with virtual environments, such as immersive reality systems.
  • Controlling assistive equipment.

Performance has risen quickly: in 2023, separate teams at Stanford and UCSF reported decoding attempted speech at about 62 and 78 words per minute, compared with roughly 150 words per minute in natural conversation. These systems operate within specific training and task constraints, however, and they do not provide general access to every thought or memory.

Brain-to-Brain Communication

Brain-to-brain interfaces attempt to communicate limited information between nervous systems. Experiments have involved recording activity from one participant or animal and delivering related signals through stimulation to another; in the 2019 "BrainNet" study, for example, three people cooperated on a simple block-rotation game using EEG to send signals and magnetic stimulation to receive them. These studies establish that constrained information transfer is possible under experimental conditions. They do not establish unrestricted sharing of thoughts, emotions, memories, or subjective experience, and the idea of a high-bandwidth network linking human minds remains speculative.

Human-AI Cognitive Integration

More ambitious proposals involve neural interfaces connected to sophisticated AI systems, with potential applications that include assisting with communication, retrieving contextual information, or improving control of assistive technology. Such systems could also introduce new dependencies. An implanted interface connected to external software may require continuous security updates, reliable support, and long-term compatibility, and questions of neural-data ownership and the user's ability to disconnect become particularly important.

Digital Identity, Mind Uploading, and Immortality

Transhumanist discussions often combine several different concepts under the term digital immortality. These concepts must be distinguished, because they range from technologies anyone can use today to proposals that may never be possible. The subsections below move from the most modest to the most radical.

Digital Preservation

Digital preservation stores information about a person, such as photographs, interviews, letters, audio recordings, and video archives. The information may survive long after the person's death and can be deeply valuable to families and historians. Preserving information is not the same as preserving the person.

Interactive Digital Legacy

An interactive legacy system organizes personal recordings and allows users to explore them conversationally. A natural-language interface may identify the most relevant recorded answer to a question, while other systems generate new responses using information previously collected about the person. Both approaches can create an impression of interaction. However, retrieval and generation provide different levels of fidelity and different risks of misrepresentation.

AI Personality Simulation

An AI personality replica attempts to imitate a person's style, voice, knowledge, or preferences, and it may produce plausible responses to questions the person never answered while alive. Those responses are model-generated predictions rather than authentic statements by the represented person. This distinction is especially important when the system discusses sensitive personal matters or makes claims about what the deceased would have wanted.

Whole-Brain Emulation

Whole-brain emulation is the hypothetical reconstruction of the functional processes of an individual brain in a computational system. A proposed process might require:

  1. Recording the brain's physical structure at sufficient resolution.
  2. Identifying neural connections and relevant cellular properties.
  3. Reconstructing the dynamic behavior of neural circuits.
  4. Modeling the interactions necessary for memory and cognition.
  5. Running the resulting model on appropriate computing hardware.
  6. Testing whether it reproduces the relevant behavior of the original system.

Small animals offer the first test cases. The full wiring diagram of the adult fruit fly brain, about 139,000 neurons, was published in 2024, and a simple simulation built from it predicted which neurons drive feeding and grooming; in March 2026 a startup reported connecting such a model to a physics-simulated fly body, a claim that has not yet been peer reviewed. Even if a computational model reproduced many observable cognitive functions, questions about subjective consciousness and personal identity would remain. Researchers do not know which physical and functional properties are sufficient for human consciousness, and a human brain is roughly 600,000 times larger than a fly's in neuron count.

The Personal Identity Problem

Suppose an artificial system accurately reproduces someone's memories, language patterns, personality, and behavior. There are several philosophical interpretations:

  • Functional continuity: The system may count as a continuation of the person if the relevant mental processes and relationships are preserved.
  • Psychological continuity: Shared memories, intentions, and personality might support some form of identity relationship, although philosophers disagree about whether this is sufficient.
  • Biological continuity: The original person may be inseparable from the continuing life of the biological organism or brain.
  • Copy interpretation: A computational reconstruction may create a new individual resembling the original without transferring the original person's subjective experience.

No experiment has established which of these interpretations would correctly describe a hypothetical uploaded human mind. The existence of two apparently identical systems would make the question especially difficult: if the biological person remained alive while a digital copy was created, both could not straightforwardly be the same continuing individual in every ordinary sense of personal identity. Philosopher Derek Parfit argued in Reasons and Persons (1984) that cases like this show identity may matter less than psychological connectedness, a view some transhumanists embrace and many critics reject.

Why a Digital Avatar Is Not Mind Uploading

A conversational AI trained on a person's recordings does not reconstruct their biological neural system; it generates or retrieves representations based on externally recorded information. A system may become very good at imitating someone without reproducing the underlying mental processes that originally produced the behavior. The phrase digital immortality therefore often describes persistence of a digital representation rather than demonstrated survival of the individual.

Digital Legacy and Information Capture

Digital legacy technologies allow people to preserve information about their lives for future generations. Unlike hypothetical mind uploading, practical digital archiving is already possible. It also connects to older practices such as oral history, genealogy, and family storytelling, which AI tools now make easier to record, organize, and search.

Existing Services and Resources

  • Storyworth ... Guided collection of family stories and personal memories.
  • MemLife ... Digital memory and personal-history service; availability and current offerings should be verified.
  • StoryCorps ... Recording and preserving personal interviews and conversations.
  • Legacy Stories ... Personal and family history preservation.
  • StoryFile ... Interactive video-based life stories.
  • HereAfter AI ... Interactive personal-memory and voice-based experiences.

These services differ in their collection methods, business models, storage arrangements, and use of AI. A conversational interface does not necessarily generate new statements, because some systems primarily retrieve recordings supplied by the person being represented. Before choosing a service, it is worth asking what happens to the recordings if the company is sold or closes.

Building a Responsible Digital Legacy

A useful legacy archive can be constructed through a deliberate process. The steps below follow standard archival practice and the safeguards ethicists recommend for AI-mediated legacies:

  1. Collect: Record interviews, significant memories, photographs, documents, and personal stories.
  2. Organize: Assign dates, topics, names, and contextual descriptions.
  3. Verify: Correct transcription errors and identify uncertain recollections.
  4. Authorize: Establish permissions for future access, voice use, images, and AI-generated material.
  5. Preserve: Maintain backups in durable and accessible formats.
  6. Describe provenance: Distinguish authentic recordings from generated interpretations.
  7. Govern: Identify who may update, share, restrict, or retire the archive.

An archive becomes more useful when viewers understand the context of each recording. It also becomes more trustworthy when it can distinguish what the person actually said from what software infers they might have said, a principle of data governance that applies equally to institutional archives. Clear labels also protect the archive's value as historical evidence for later generations.

Digital Legacy Is Broader Than a Chatbot

A legacy archive need not be built around a conversational AI at all. Digital preservation can include many forms of material:

  • Personal histories and interviews.
  • Family photographs.
  • Artistic and creative works.
  • Correspondence.
  • Recorded music.
  • Videos and spoken recollections.
  • Genealogical information.
  • Personal values and life lessons.
  • Important decisions and their explanations.

A well-organized archive may remain valuable even if AI software or a particular commercial service becomes unavailable. For long-term preservation, commonly supported file formats, redundant storage, and documented access arrangements can be more important than a sophisticated interface. Ordinary video files and printed transcripts, for example, are likely to outlast any particular app.

StoryFile

  • StoryFile ... Interactive video conversations and personal stories.

StoryFile provides a method of recording interviews that viewers can later explore through natural-language questions. The concept is to capture answers to a range of questions in advance, then use software to identify and present appropriate recorded responses. This creates an experience in which an audience can ask questions and receive answers from a recorded person.

How It Works

Systems of this kind rely on preparation rather than generation. A typical interactive interview involves:

  1. Recording the subject answering a structured set of questions.
  2. Storing the answers as indexed video segments.
  3. Processing and organizing the recorded material.
  4. Accepting questions from viewers.
  5. Matching a question to a relevant available answer, a form of semantic search.
  6. Playing the recorded answer.

Depending on the product and implementation, additional AI-assisted features may be available. The core preservation principle is that the subject's authentic recorded responses remain distinguishable from machine-generated material. Because products change over time, users should check whether a given service can ever produce answers the subject did not record.

Why It Is Useful

The approach can support family history, education, museum exhibits, institutional knowledge, and personal legacy. It allows future audiences to explore an individual's experiences in a more interactive way than watching a conventional linear documentary. The value comes from access to authentic testimony, not from creating a conscious continuation of the interview subject.

Letting Future Generations Speak with Holocaust Survivors

One of the most significant applications of interactive testimony technology involves preserving the experiences of Holocaust survivors. As the population of surviving eyewitnesses declines, museums and educational institutions are developing methods to keep their firsthand accounts accessible to future generations. These projects also offer a model of how interactive recordings can be built with historical integrity in mind.

USC Shoah Foundation: Dimensions in Testimony

The Dimensions in Testimony project from the USC Shoah Foundation is an established example. It enables audiences to ask questions and receive responses drawn from recorded interviews with Holocaust survivors and other witnesses to genocide, and its development has involved the USC Institute for Creative Technologies and museum partners. The technology is designed to preserve access to personal testimony rather than reconstruct the survivor as an independent artificial intelligence.

How the System Preserves Authenticity

Interview participants answer an extensive collection of questions during dedicated recording sessions; the foundation reports that about 1,000 questions are posed and answered, and each answer is preserved as a separate video recording. When a visitor asks a question, natural-language processing turns it into search terms, identifies the most appropriate recorded response, and plays it. Trained staff periodically review the system logs and manually link a better answer when the match was poor.

This design is important because it helps avoid generating statements that a survivor never actually made. The technology therefore has a different purpose from a generative AI avatar that invents new dialogue in a person's style. It accepts occasional imperfect matches as the price of never putting words in a witness's mouth.

Educational Benefits

Interactive testimony offers something a recorded lecture or written transcript cannot: the chance to ask a witness one's own question. Its potential benefits include:

  • Preserving eyewitness accounts: Allows authentic testimony to remain accessible as time passes.
  • Supporting inquiry-based learning: Encourages students to ask questions rather than only receive predetermined information.
  • Providing historical context: Connects historical events to individual experiences.
  • Encouraging empathy: Helps audiences understand the personal consequences of persecution and genocide.
  • Supporting museums and educators: Provides interactive resources that can complement traditional archives.

These benefits must be evaluated through educational outcomes rather than assumed from technological novelty alone. Museums and schools that use the exhibits can help by studying what visitors learn and remember over time, not just how many people use the displays.

Historical Integrity and Ethical Safeguards

Historical testimony must preserve the distinction between the actual witness and the technology presenting their testimony. Essential safeguards include:

  • Using authentic recordings.
  • Preserving the original testimony.
  • Avoiding fabricated quotations.
  • Identifying the source and date of recordings.
  • Obtaining informed participation and consent.
  • Providing historical context.
  • Maintaining institutional review.
  • Correcting inappropriate question-answer matches.
  • Explaining clearly that the audience is interacting with a recording-based system.

This is especially important when the technology is used to educate children or discuss historical atrocities. The goal is not to make an artificial person appear alive; it is to preserve and share the knowledge and experiences of actual witnesses. Generative "deepfake" survivors, by contrast, could hand Holocaust deniers a ready excuse to dismiss genuine testimony as synthetic.

Posthumous Communications Technology

Posthumous communications technology refers to systems that allow living people to interact with digital representations of deceased individuals, an emerging part of the broader digital legacy and grief-technology sector. The field includes recorded interactive biographies, text-based conversational agents, AI-generated voices, animated photographs, and more sophisticated multimodal avatars. Such systems may be used to remember loved ones, preserve personal stories, or explore unresolved questions. They also raise substantial psychological, ethical, and legal concerns.

How Posthumous Communication Systems Work

Generative systems assemble a person's digital traces and use AI to recombine them. A typical system may combine:

The information can help a model approximate how the person might have communicated. Some implementations retrieve authentic historical material, while others generate new dialogue, and the distinction should always be disclosed. A generated response is not a statement actually made by the deceased.

AI Griefbots and Digital Resurrection

The terms griefbot, deadbot, and digital ghost generally refer to systems that simulate interaction with someone who has died. Digital resurrection is sometimes used in commercial or popular descriptions, but it is not a scientifically demonstrated restoration of the deceased person's consciousness, and the term may be misleading if it encourages users to believe that a representation possesses the memories, feelings, or continuing existence of the original individual. The same techniques underlie deepfakes, which is why disclosure matters so much.

These systems may provide comfort for some users. They may also produce inaccurate statements, intensify emotional dependency, or alter recollections of the person being represented, and research into their long-term psychological effects remains limited. Public reaction can be sharply negative: when the startup 2Wai released an app in November 2025 that builds a talking avatar of a relative from about three minutes of video, its promotional clip of a woman confiding in her late mother drew widespread condemnation as exploitative.

Potential Benefits

Supporters and some bereaved users point to real value in these tools. Possible benefits include:

  • Preserving personal memories.
  • Providing access to recorded stories and voices.
  • Supporting remembrance.
  • Helping families share their history.
  • Offering new forms of memorialization.
  • Making recorded personal knowledge easier to explore.

Some users describe these interactions as emotionally meaningful. However, emotional significance does not establish that the representation is the original person, nor does it demonstrate that frequent use improves grief-related outcomes. Research on actual users so far consists mainly of small interview studies, and long-term controlled trials are lacking.

Psychological and Ethical Risks

The risks are better documented in ethical analysis than in clinical studies, but they are specific. Potential risks include:

  • Misrepresentation: The system may attribute invented statements or views to the deceased.
  • Emotional dependence: Users may develop an unhealthy reliance on repeated interactions.
  • Distorted memories: Generated dialogue may become confused with genuine memories.
  • Consent problems: The deceased may not have authorized their data or likeness to be used this way.
  • Commercial exploitation: Providers may monetize emotionally sensitive interactions.
  • Privacy exposure: Personal information about the deceased and living relatives may be revealed.
  • Identity misuse: The representation could be used to impersonate someone or suggest endorsements the person never gave.
  • Impact on children: Young users may have particular difficulty understanding the distinction between a living person and a digital simulation.

These risks are central considerations, not minor implementation details. Related concerns about AI companions have already changed industry practice: after lawsuits alleging harm to teenagers, Character.AI barred users under 18 from open-ended chats with its characters from November 2025. Ethicists and mental health researchers have urged that grief technologies be studied with the same care as other interventions aimed at vulnerable people.

Consent Before and After Death

Consent is unusually complicated in this field because the person being simulated is usually not the person using the system. Ethical design should address the interests of several distinct parties:

  • The data donor is the person whose information is used to construct the representation.
  • The data recipient may be a family member or institution that receives or controls the information.
  • The interactant is the person who uses the system.

These individuals may have different preferences and interests. Consent by a surviving family member does not automatically establish that the deceased would have approved of the representation, and a person agreeing to be recorded does not necessarily imply consent to unrestricted generative impersonation. Responsible arrangements should specify permitted uses, audience, retention, commercial exploitation, and procedures for withdrawing access.

The Right to Retire a Digital Persona

A digital legacy may eventually become emotionally burdensome, inaccurate, or inappropriate. Users and authorized stewards should have meaningful ways to restrict access, deactivate a system, or delete personal information when legally and technically possible, and some researchers have proposed a form of digital funeral, a structured process for retiring a digital representation respectfully. A service that allows an avatar to be created but provides no clear retirement or deletion procedure presents significant governance concerns.

Companies and Examples in Digital Afterlife Technology

The following examples illustrate different approaches to preserving or simulating personal identity. Their services and business models may change over time, so the descriptions below should be treated as snapshots. Availability, pricing, and features should always be confirmed directly with providers.

You, Only Virtual (YOV)

YOV has developed technology intended to create interactive digital representations of individuals, and the company has described a concept called a Versona, an AI-mediated representation of a person based on personal information and communication patterns. Its stated objective has involved preserving aspects of relationships and enabling continued interactions. The claims should be interpreted as descriptions of a digital simulation, since there is no evidence that such a service preserves or transfers consciousness.

StoryFile

StoryFile emphasizes recorded responses and interactive biographical experiences. Its preservation model differs from systems primarily designed to generate new statements in the voice of the deceased. This distinction can make recorded-answer systems particularly useful when authenticity is more important than conversational flexibility.

Replika

Replika is an AI companion service. It is relevant to transhumanism and digital identity because it demonstrates how users may form emotional relationships with conversational AI, a theme explored further under Personal Companions. However, a companion that develops a personalized interaction style is not necessarily a replica of a specific real person, and the emotional, ethical, and psychological issues overlap with posthumous avatars without being identical.

Other Digital Legacy Services

Several other services occupy different points on the spectrum between preservation and simulation, each making a different trade-off between authenticity and interactivity. Examples include:

  • HereAfter AI focuses on preserving personal histories and enabling interactive access to recorded memories.
  • StoryCorps emphasizes authentic recorded conversations and archival preservation.
  • Storyworth uses guided questions and other methods to help families collect biographical stories.
  • 2Wai generates conversational video avatars from short recordings and launched its beta app in November 2025 amid public criticism.

These approaches illustrate a spectrum from conventional memory preservation to increasingly interactive AI-mediated representations. The choice between them should depend on the intended purpose, fidelity requirements, privacy expectations, and long-term stewardship arrangements.

Black Mirror: 'Be Right Back'

The Black Mirror episode Be Right Back, first broadcast in 2013, provides a fictional examination of AI-mediated relationships with the deceased. The story follows Martha, a woman whose partner Ash dies unexpectedly, and a service that constructs a digital imitation of Ash using his online communications and other recorded information. Martha initially interacts with the representation through written messages; the system later becomes capable of voice interaction, and the story develops toward a physical artificial embodiment. Although the representation resembles Ash, Martha discovers that its behavior does not fully reproduce the complexity of the person she knew.

The Central Question

The episode explores the difference between reproducing recognizable behavior and preserving an individual. A model can imitate someone's conversational patterns without possessing the same memories, understanding, emotional responses, or subjective experience. The story also illustrates how grief may change a person's willingness to accept a simulation as a substitute for a real relationship.

Relevance to Current Technology

When the episode aired, its premise was science fiction. Several capabilities it portrayed now exist in limited or partial forms:

  • AI-generated conversational responses.
  • Personalized chatbots.
  • Voice cloning.
  • Facial animation.
  • Interactive digital avatars.
  • Conversational systems trained or conditioned on personal information.

The fictional depiction of a complete physical and psychological replacement remains beyond demonstrated capabilities, so the episode is useful as a thought experiment, not as a forecast or technical description. It raises questions that current developers must consider:

  • Who owns a person's digital identity?
  • Should a replica be allowed to invent new memories?
  • Can a simulation provide comfort without creating harmful dependence?
  • What should happen when the representation becomes inaccurate?
  • Can a loved one meaningfully consent on behalf of someone who has died?
  • Should a replica be permitted to remain indefinitely available?

The Future: Life After Death | Netflix

The Netflix documentary series The Future Of, released in 2022, includes an episode titled "Life After Death" that examines technologies and cultural practices associated with death, remembrance, and posthumous identity. Topics include digital representations, voice simulation, memorial technologies, and changing practices surrounding death. The episode also considers how emerging technologies may influence the ways people remember deceased loved ones.

Thanatology

Thanatology is the interdisciplinary study of death, dying, bereavement, and related human experiences, and its subject matter includes medical, psychological, social, cultural, ethical, and spiritual dimensions. Thanatologists may conduct research, support people confronting death, or contribute to education and professional practice. The documentary features thanatologist Cole Imperi and examines possible future changes in end-of-life services.

Why This Matters to Transhumanism

Transhumanism often focuses on extending life or overcoming biological limitations. Posthumous technologies raise a different question: what, if anything, can technology preserve after biological life ends? There are at least three distinct objectives:

  • Biological continuation: Extending the functioning life of the organism.
  • Informational preservation: Preserving stories, images, and other information.
  • Conscious continuation: Preserving the individual's subjective existence.

Current digital legacy systems primarily address informational preservation and do not demonstrate biological or conscious continuation. The documentary is best understood as an exploration of cultural possibilities rather than proof that digital immortality has been achieved.

Ethical and Philosophical Challenges

The technologies associated with transhumanism introduce questions that conventional medical and information-technology ethics do not always fully resolve. Medical ethics assumes a patient seeking treatment, and data ethics assumes information that can be separated from the person; enhancement and neurotechnology strain both assumptions. The subsections below outline the main areas of concern.

Human Dignity and Bodily Autonomy

People should have meaningful authority over interventions affecting their bodies and minds, and consent must reflect an adequate understanding of the risks, benefits, alternatives, and uncertainties. The ethical assessment becomes more difficult when enhancement technologies are irreversible, experimental, or dependent on a company for continued operation. An implant whose manufacturer goes out of business can leave its user with hardware that cannot be repaired or updated.

Cognitive Liberty and Neurorights

Neurotechnology has prompted proposals for new rights, or new interpretations of existing ones. Advocates of "neurorights," including ethicists Marcello Ienca and Roberto Andorno and Columbia University neuroscientist Rafael Yuste, have proposed several related protections, among them:

  • Cognitive liberty concerns an individual's freedom to think and direct their mental life without inappropriate external interference.
  • Mental privacy concerns protection of information inferred from neural activity or other personal signals.
  • Mental integrity concerns protection from unwanted interference with neural processes.

These concepts have become more important as neurotechnology enables increasingly detailed measurement and stimulation. Neural recordings can reveal task-specific information, but their interpretation remains context-dependent, and claims that current BCIs can read any thought directly are misleading. Nevertheless, neural information requires careful privacy and security protection, and the law has begun to respond. Chile amended its constitution in 2021 to protect mental integrity; in the United States, Colorado and California added neural data to their privacy laws in 2024, Montana and Connecticut followed in 2025, and in September 2025 Senators Maria Cantwell, Chuck Schumer, and Ed Markey introduced the MIND Act, which would direct the Federal Trade Commission to study how neural data should be protected nationally.

UNESCO's Neurotechnology Framework

In November 2025, UNESCO's member states adopted the Recommendation on the Ethics of Neurotechnology at the organization's General Conference in Samarkand, and it entered into force on November 12. The framework addresses the protection of human dignity, mental privacy, autonomy, and related rights, and it also emphasizes responsible innovation, equitable access, and strictly voluntary use of neurotechnology in the workplace. A UNESCO Recommendation provides an international normative framework, but it does not automatically create identical binding legislation in every country; its influence will depend on how governments translate it into law and governance.

Therapy Versus Competitive Enhancement

A society may strongly support restoring a person's ability to communicate while taking a more cautious approach toward elective enhancement intended to provide competitive advantage. Questions include:

  • Is the intervention medically necessary?
  • Does it provide benefits that outweigh the risks?
  • Is access equitable?
  • Could it create coercive pressure?
  • Would it undermine fairness?
  • Can its effects be reversed?
  • Who bears responsibility for harmful outcomes?

These questions must be evaluated according to the specific technology and setting. Sport offers a long-running precedent: anti-doping rules already distinguish therapeutic use of a drug from performance enhancement, and the difficulty of drawing that line in practice previews debates that cognitive and genetic enhancement may bring to education and work.

Genetic Enhancement and Future Generations

Heritable genetic modification introduces particularly difficult issues because the consequences may extend to descendants who could not consent. Unlike treatment of an adult's somatic cells, embryo or germline modification can change inherited genetic information, with potential problems that include unexpected mutations, developmental effects, social pressures, and unequal access. Somatic gene editing for serious disease should not be conflated with attempts to engineer complex traits in future children.

The question is no longer purely hypothetical. In late 2025, several US startups announced plans to research embryo editing, including Preventive, founded by gene-editing scientist Lucas Harrington with a reported $30 million from investors including Sam Altman and Brian Armstrong; the company says it will not proceed to clinical use unless safety can be established. Meanwhile, companies offering polygenic screening of IVF embryos, which ranks embryos by predicted traits without editing them, have drawn criticism from geneticists who say such scores predict little for individuals and revive eugenic thinking.

Personal Identity and Consciousness

Transhumanist enhancement can raise a question of continuity: how much could a person's body or brain change before they should no longer be considered the same individual? There is no universally accepted answer. Some philosophical views emphasize psychological continuity, while others emphasize biological continuity or the continuity of a conscious subject, and the difficulty becomes especially apparent in proposals involving substantial neural replacement or mind uploading. As Susan Schneider argues, a technology that reproduces information or intelligence might still fail to preserve the original person's conscious experience.

The Value of Human Vulnerability

Not all critics of transhumanism object to medical progress. Some question whether vulnerability, dependence, mortality, and imperfection contribute to important human relationships and moral practices, as Michael Sandel argues in defending an attitude of "giftedness" toward human abilities. For example, overcoming a disability may be valuable without implying that people living with disabilities possess less dignity or worth, and disability scholars have warned that enhancement rhetoric can imply exactly that. A careful discussion must distinguish improving opportunities from imposing a narrow conception of the ideal human.

Recent Developments

Developments from 2024 through October 2026 have produced meaningful advances in neural interfaces, genome editing, sensory restoration, brain mapping, and ethical research. These advances provide a more concrete basis for evaluating transhumanist claims than earlier predictions based mainly on technological extrapolation. They also show a consistent pattern: real progress on restoring specific functions, alongside little evidence for the most radical claims.

May 2024: Growing Ethical Scrutiny of Digital Afterlife Services

In May 2024, researchers Tomasz Hollanek and Katarzyna Nowaczyk-Basińska of Cambridge's Leverhulme Centre for the Future of Intelligence published a peer-reviewed analysis of generative AI in digital afterlife applications. They explored risks involving consent, misrepresentation, psychological harm, and commercial use, using speculative design scenarios to examine possible consequences, and recommended transparency, meaningful consent, appropriate restrictions on access, and procedures for retiring digital replicas. The paper's significance lies in moving the discussion beyond the question of whether the technology can imitate a person. The more important question becomes how to govern systems that may influence the memories and emotions of people who interact with them. The paper is an ethical analysis rather than a clinical demonstration of harm or benefit.

May 2024: A Cubic Millimeter of Human Cortex

In May 2024, researchers at Harvard University and Google published a nanoscale reconstruction of a cubic millimeter of human temporal cortex, removed during epilepsy surgery. The map contains about 57,000 cells, 150 million synapses, and 230 millimeters of blood vessels, and its 1.4 petabytes of data revealed structures never seen before, including rare neurons connected by unusually strong bundles of synapses. The sample is roughly one-millionth of a human brain, which illustrates how far whole-brain human connectomics, let alone emulation, remains from current capability.

October 2024: Complete Adult Fruit-Fly Brain Connectome

In October 2024, the FlyWire collaboration published a reconstruction of the adult fruit-fly brain containing approximately 139,000 neurons and more than 50 million synaptic connections. The work involved large-scale electron microscopy, computational reconstruction, and extensive review, and produced a detailed wiring diagram of a complex nervous system, an important advance in connectomics, the study of neural connections. In the same issue of Nature, Philip Shiu and colleagues showed that a simple simulation built only from this wiring and predicted neurotransmitter types could correctly predict which neurons drive feeding and grooming, a hypothesis they confirmed in living flies.

However, a wiring diagram is not a functioning recreation of the brain. It does not completely represent neurotransmitter dynamics, cellular physiology, learning history, or conscious experience. The result therefore advances neuroscience without demonstrating whole-brain emulation of a human being.

February 2025 and January 2026: A Lifespan Drug for Dogs Advances

In February 2025, the FDA's Center for Veterinary Medicine accepted the "reasonable expectation of effectiveness" section of Loyal's conditional-approval application for LOY-002, a daily pill intended to extend the healthy lifespan of dogs aged 10 and older, and in January 2026 the company announced acceptance of its safety section. If the remaining manufacturing review succeeds, veterinarians could prescribe the drug while the STAY study, a four-year placebo-controlled trial in more than 1,000 dogs, gathers the lifespan data required for full approval. The case matters to longevity research because it would be the first regulatory approval of a drug for lifespan extension itself in any species. It is not evidence of a human anti-aging drug, and the effectiveness judgment rests on preliminary data rather than completed lifespan results.

March 2025: Streaming Brain-to-Voice Communication

In March 2025, researchers from UC Berkeley and UCSF published results from a brain-to-voice neuroprosthesis developed for a clinical trial participant with severe paralysis and inability to produce intelligible speech. The system used high-density recordings from the speech-related sensorimotor cortex, and neural signals were processed through trained machine-learning models to generate synthesized speech. The decoding framework operated in increments of approximately 80 milliseconds, which supported more continuous speech production than systems that required lengthy delays to accumulate and process intended language. The study demonstrated an important advance in restoring communication. Its limitations included a small clinical evidence base, patient-specific calibration, and the need to establish long-term reliability and broader generalizability.

April 2025: Mouse Brain Connectivity and Function

In April 2025, the MICrONS Consortium published a large-scale functional connectomics dataset from mouse visual cortex, combining neural activity measurements with electron microscopy. The reconstructed material contained more than 200,000 cells and approximately 524 million synaptic connections, and researchers also collected functional responses from tens of thousands of neurons while the mouse viewed visual stimuli. Combining connectivity with functional measurements provides evidence about how neural circuits process information, a step beyond purely anatomical brain mapping. Nevertheless, the dataset covers only a small portion of a mouse brain and does not constitute a complete mouse-brain simulation, much less a human mind upload.

April 2025: First FDA Clearance for a Next-Generation BCI Electrode

In April 2025, Precision Neuroscience received FDA 510(k) clearance for its Layer 7 Cortical Interface, a film thinner than a human hair carrying 1,024 electrodes that rests on the brain's surface without penetrating it. The clearance allows the array to be implanted for up to 30 days for recording, monitoring, and stimulation, extending research use from hours during surgery to weeks. It is a component of a planned permanent wireless system rather than a long-term implant, but according to the company it was the first full regulatory clearance for one of the new generation of BCI developers.

May 2025: Personalized Gene Editing for a Rare Disease

In May 2025, Kiran Musunuru, Rebecca Ahrens-Nicklas, and colleagues reported a personalized gene-editing treatment for an infant, KJ Muldoon, with carbamoyl-phosphate synthetase 1 (CPS1) deficiency, a severe inherited metabolic disorder affecting the body's ability to handle nitrogen-containing waste. The team at Children's Hospital of Philadelphia and Penn Medicine developed a customized base-editing treatment delivered through lipid nanoparticles in about six months, and the infant received his first infusion in February 2025. The early report described improved tolerance for dietary protein and reduced need for one nitrogen-scavenging medication, with no serious treatment-related adverse events during the short initial observation period.

This was a major proof of concept for individualized gene editing, and it reshaped regulation: in November 2025, FDA leaders proposed a "plausible mechanism" pathway that could allow approval of bespoke therapies aimed at a known genetic cause after success in several consecutive patients. However, the evidence came from a single patient with limited follow-up. It did not establish broad safety, long-term efficacy, or the feasibility of using genome editing to improve complex human traits.

May 2025: An AI Avatar Speaks for a Homicide Victim

In May 2025, an Arizona court allowed the family of Christopher Pelkey, who was killed in a 2021 road-rage shooting, to present an AI-generated video in which a likeness of Pelkey, built from photographs and a voice profile, delivered a victim impact statement at his killer's sentencing. Pelkey's sister wrote the script, and the avatar opened by disclosing that it was an AI recreation. Legal experts described it as likely the first such use in a US court; the judge praised the statement, while the defense signaled that its influence on the sentence could be raised on appeal. The case shows how quickly posthumous avatars are moving from private grief into public and legal settings, where questions of consent, authenticity, and fairness carry institutional weight.

June 2025: More Expressive Brain-Computer Speech

A study published in Nature in 2025 by a UC Davis team demonstrated brain-to-voice synthesis using an implanted BCI in a participant with amyotrophic lateral sclerosis (ALS). The researchers used signals recorded through 256 intracortical microelectrodes, and the system generated speech with real-time auditory feedback while decoding aspects of vocal expression, allowing the participant to modify intonation and produce short sung melodies. This matters because natural communication involves more than transmitting words; timing, emphasis, and prosody contribute to meaning and interpersonal connection. The study demonstrated feasibility in a specialized clinical setting, not a generally available neural speech replacement.

October 2025: Retinal Prosthesis Improves Functional Vision

A study published online in October 2025 evaluated the PRIMA retinal prosthesis system in people with geographic atrophy caused by age-related macular degeneration. The system combines a subretinal photovoltaic implant with specialized glasses that project near-infrared signals. The overall study enrolled 38 participants, and among the 32 who completed 12 months of follow-up, 26 demonstrated clinically meaningful improvement in measured visual acuity; the researchers also reported serious adverse events, many occurring around the surgical period. The result illustrates the potential for combining implanted electronic components with external processing to restore aspects of sensory function. The study did not demonstrate restoration of completely normal vision, and the findings require continued follow-up and evaluation.

Late 2025: Embryo-Editing Startups and a Safety Setback for In Vivo CRISPR

In October and November 2025, the startup Preventive announced it had raised about $30 million to research heritable genome editing, making it at least the third US company that year to pursue technology for gene-edited babies. Its founder pledged not to attempt clinical use unless safety could be established, but critics, including gene-editing pioneers, called the effort dangerous and a distraction from therapies for living patients. The same autumn showed how much remains to be learned even for somatic editing: Intellia's phase 3 trials of an in vivo CRISPR therapy for transthyretin amyloidosis were placed on FDA hold in October 2025 after a participant developed severe liver injury, and resumed in early 2026 with enhanced monitoring. Together, these events show heritable enhancement being pursued commercially while basic safety questions about editing in adults are still being resolved.

November 2025: International Neurotechnology Ethics Framework

In November 2025, UNESCO adopted its Recommendation on the Ethics of Neurotechnology, an important policy response to the growing ability of technologies to measure and influence neural activity. It emphasizes human dignity, autonomy, mental privacy, and responsible research, and its adoption followed the introduction of the MIND Act in the US Senate two months earlier. The Recommendation is significant because many transhumanist technologies could eventually influence not only physical capability but aspects of cognition and personal decision-making. Its practical impact will depend on national implementation, industry practices, research governance, and public accountability.

November 2025: Backlash Against a Commercial Griefbot

On November 11, 2025, the Los Angeles startup 2Wai released a beta app whose "HoloAvatar" feature builds a conversational video avatar from about three minutes of footage. A promotional video showing a pregnant woman talking with an avatar of her late mother, and the avatar later reading to her child, was viewed millions of times and drew widespread condemnation as exploitative and dystopian, although the company said its aim was to preserve family stories. The episode showed that public tolerance for generative replicas of the dead is far lower than for recorded-testimony systems, and it echoed the specific risks ethicists had described the year before.

January 2026: Investment in Human-AI Interfaces

In January 2026, Merge Labs, a brain-computer interface company co-founded by OpenAI chief executive Sam Altman, announced a $252 million seed round from investors including OpenAI, Bain Capital, and Valve co-founder Gabe Newell. The company describes its goal as bridging biological and artificial intelligence and is pursuing noninvasive approaches based on ultrasound rather than implanted electrodes. The same month, Neuralink reported 21 participants with its implant across four countries, while its planned Blindsight vision implant still awaited a first human recipient. The investment signals that leading AI companies now see neural interfaces as part of their long-term strategy, although Merge Labs had not published human results.

March 2026: An Embodied Fruit-Fly Brain Emulation

In March 2026, the startup Eon Systems released video of what it called the first embodied whole-brain emulation to produce multiple behaviors: a model of the fruit-fly connectome, based on the 2024 work of Shiu and colleagues, connected to a physics-simulated fly body that walked, groomed, and fed in a virtual environment. Its leaders said the next targets are a mouse brain, with about 70 million neurons, and eventually a human brain. Independent observers noted that the new body-integration work had not been peer reviewed or fully released, and that a simplified neuron model leaves out much of real neural physiology. The demonstration is a genuine milestone for computational neuroscience, but it is far from evidence that a human mind could be uploaded.

June 2026: Ethical Principles for AI Griefbots

A June 2026 paper in the Journal of Responsible Technology examined the principles of consent and non-addiction for AI systems that simulate deceased people, arguing that these technologies should protect the interests of both the person represented and the people interacting with the simulation. It proposed safeguards against emotional manipulation, excessive dependence, and inappropriate use involving minors. The same month, Giovanni Spitale and Federico Germani of the University of Zurich published a design framework in Ethics and Information Technology that translates such principles into concrete requirements, such as premortem intent, mutual consent, clear disclosure, and minimal behavioral agency. These papers provide normative ethical frameworks; they do not establish through clinical trials that griefbots are beneficial or harmful for all grieving users. An important research question remains how different interaction styles and patterns of use affect grief, memory, and relationships over time.

June to September 2026: A Fully Implanted Speech BCI Enters Trials

On June 17, 2026, Paradromics and University of Michigan Health announced the first implantation of the company's Connexus brain-computer interface in its FDA-approved Connect-One study, in a woman who has difficulty speaking because of motor neuron disease. The fully implanted, wireless system records from 421 microelectrodes, and in September the company reported that the participant had used it to generate real-time speech, choosing her own words and answering open-ended questions. These are company-reported results from a single participant, without published data on accuracy, vocabulary, or long-term durability, and the study will follow her for six years.

July 2026: Expanded Access to CRISPR-Based Treatment

On July 1, 2026, the U.S. Food and Drug Administration expanded the approved use of Casgevy (exagamglogene autotemcel) to patients aged two years and older with sickle cell disease or transfusion-dependent beta thalassemia, lowering the previous threshold of 12. The treatment involves gene editing of a patient's blood-forming stem cells and represents an established clinical application of CRISPR-based technology for selected serious diseases; Vertex estimated that about 5,500 additional US children became eligible. However, the treatment requires specialized medical procedures, including chemotherapy to make room for the edited cells, and careful follow-up. Its approval should not be interpreted as evidence that general human genetic enhancement is safe or clinically available.

September 2026: MIT Examines Mind Uploading

In September 2026, the MIT McGovern Institute published a discussion with researchers concerning whether human consciousness could be uploaded into a machine. The researchers identified major scientific obstacles, including the enormous complexity of the human brain, incomplete knowledge of neural information processing, and the absence of an accepted account of the physical requirements for consciousness, and they also considered whether a digital reconstruction would preserve the identity of the original person. Their views differed: some thought consciousness transfer could eventually be possible, while others doubted that consciousness can be reduced to mechanisms in the way other biological phenomena can. The discussion reflects increasing scientific attention to questions once primarily associated with speculative philosophy and science fiction. It does not report a successful consciousness transfer.

October 2026: Optogenetic Restoration of Visual Function

On October 7, 2026, researchers led by José-Alain Sahel and Botond Roska published results from an experimental optogenetic treatment for advanced retinitis pigmentosa, two days after optogenetics pioneers received the Nobel Prize in Physiology or Medicine. The study involved 10 participants with severe vision loss, each of whom received a gene-delivery treatment intended to make selected retinal ganglion cells responsive to light; specialized goggles then converted changes in the scene into pulses of amber light designed to activate the introduced protein. The researchers reported increased measured light sensitivity in seven participants, six of whom met the study's threshold for clinically meaningful improvement. Ocular adverse events were reported, including one severe but transient event involving retinal artery occlusion immediately after injection, and the primary objective was safety in a small, open-label study. The findings suggest that gene delivery combined with external electronics may restore selected aspects of visual function, but they do not establish normal vision or broad clinical effectiveness.

Major Unresolved Questions

Transhumanism involves several scientific uncertainties that cannot be resolved merely by projecting current trends into the future. Each of the questions below would require new kinds of evidence, not just faster versions of today's technologies. Some may never have definitive answers.

Can Human Aging Be Radically Delayed?

Researchers have identified biological mechanisms associated with aging, but these processes interact with one another, and targeting one mechanism may improve a particular outcome without substantially changing overall aging. Large, well-controlled human studies with clinically meaningful endpoints are needed to determine whether experimental treatments increase healthspan or lifespan. Validated biomarkers could shorten that wait, but none yet substitutes for long-term outcomes.

Can Neural Interfaces Provide General Cognitive Enhancement?

BCIs have demonstrated impressive results in carefully defined tasks, but general cognitive enhancement would require much broader understanding of how neural systems encode and integrate information. It would also require interfaces that remain reliable across activities and over long periods. There is currently no demonstrated general-purpose neural interface that provides unrestricted access to knowledge or substantially expands human intelligence.

Can a Digital Brain Be Conscious?

Researchers disagree about which physical or computational properties are necessary for conscious experience. Some theories emphasize information processing, while others emphasize integrated physical processes or particular neural dynamics. There is no accepted empirical method for establishing that a computational reconstruction of a person would have the same subjective identity as the original.

Can AI Replicas Preserve Authentic Personal Identity?

Current AI replicas can imitate selected patterns of behavior and may preserve recognizable speech or memories. However, their outputs can vary with model design, training data, system instructions, and interaction context, and a replica may eventually diverge significantly from the original person's known values and behavior. Developers must determine how to preserve authenticity and clearly identify generated material.

Should Every Enhancement Be Pursued?

The ability to improve a measurable capability does not necessarily establish that doing so improves overall well-being. An intervention might improve performance while reducing autonomy, imposing medical risks, creating social pressure, or changing relationships. The evaluation of enhancement must therefore include individual, social, and ethical consequences.

Future Research Directions

Several research areas could materially affect transhumanist possibilities over the coming decades. Most are being pursued for medical reasons rather than enhancement, which means their results will arrive first as treatments and only later, if at all, as upgrades. The directions below are the ones most likely to shift the debate.

More Reliable Neuroprosthetics

Future research will focus on longer-lasting electrodes, more stable neural decoding, improved sensory feedback, and safer surgical approaches, including minimally invasive and fully implanted wireless designs. Broad clinical adoption will require evidence of reliability, patient benefit, manageable risks, and sustainable maintenance. Several companies are now preparing for the larger pivotal trials that regulators require before marketing approval.

Regenerative Medicine and Biological Repair

Cell therapies, tissue engineering, and molecular treatments may expand the range of damaged biological structures that can be repaired. The main challenge will be moving from carefully controlled experimental results to reproducible and safe clinical outcomes. Regulatory experiments such as the FDA's proposed "plausible mechanism" pathway for bespoke therapies may change how quickly individualized treatments reach patients.

Better Models of the Aging Process

Researchers will continue investigating cellular senescence, immune aging, metabolic pathways, epigenetic changes, and the relationships among aging processes. Validated measures of meaningful biological change would make long-term trials easier to evaluate, and veterinary studies in companion dogs may provide the first regulated test of a drug aimed at aging itself. Large human cohorts with repeated biological measurements will be needed to show whether proposed biomarkers actually predict health outcomes.

Human-Centered AI Augmentation

More capable AI may improve cognitive assistance without requiring invasive implants. The most useful systems may combine personalized information access, decision support, and automation while preserving the user's ability to understand and control outcomes. Research on how people come to over-rely on AI, and how to design against it, will matter as much as gains in raw capability.

Neural Mapping and Computational Neuroscience

Connectomics and large-scale neural recording may reveal additional relationships between brain structure and function, and these developments could improve neuroprosthetics and models of cognition. Projects to map a whole mouse brain, roughly 500 times larger than a fly brain in neuron count, are the next major benchmark. They do not automatically establish the possibility of mind uploading.

Responsible Digital Legacy

AI-mediated personal archives may become more accurate, accessible, and interactive. Important research questions include:

  • How should consent be documented?
  • How can authentic recordings be distinguished from generated responses?
  • How can users control the representation of their personal identity?
  • What happens if a provider goes out of business?
  • How can systems prevent fabricated or misleading statements?
  • How should children interact with digital representations of deceased relatives?
  • When should an avatar be retired?
  • How does long-term use influence memory, grief, and psychological well-being?

These questions concern the quality and ethics of remembrance rather than demonstrated digital immortality. Answering them will require collaboration among technologists, grief researchers, archivists, and the families who use these systems.

Additional Viewing

The talks and documentaries below were chosen to deepen specific sections of this page, from the philosophy of enhanced minds to the laboratories building speech neuroprostheses and personalized gene editors. Older selections are kept for historical context, and their predictions should be read alongside the evidence summarized above. Each entry notes which part of the article it supports.

AI and Artificially Enhanced Brains | Susan Schneider

Load video
YouTube

Philosopher and cognitive scientist Susan Schneider examines the possibility of merging human minds with artificial intelligence. She explores consciousness, personal identity, and the risk that some proposed enhancements might produce a computational replica without preserving the original conscious individual, which makes the lecture a companion to the Personal Identity and Consciousness section.

AI and Artificially Enhanced Brains | The Royal Institution, 2020

Connecting Brains: The BrainNet | VPRO Documentary

Load video
YouTube

This documentary follows scientific journalist Rob van Hattum as he investigates neural interfaces and experiments involving brain-to-brain communication. It includes work associated with neuroscientist Miguel Nicolelis and provides useful historical context for distinguishing genuine neural information transfer from speculative mind-sharing claims, as discussed under Brain-to-Brain Communication.

Connecting Brains: The BrainNet | VPRO Backlight, 2014

Letting Future Generations Speak With Holocaust Survivors | CBS 60 Minutes

Load video
YouTube

This extended report examines interactive recorded testimony and the effort to preserve firsthand Holocaust accounts for future audiences. It illustrates how carefully prepared video recordings and natural-language matching can create conversational educational experiences without requiring the system to invent testimony, the approach described in the Dimensions in Testimony section.

From the 60 Minutes Archive: Letting Future Generations Speak With Holocaust Survivors | CBS News, 2023

Body by Design | Natasha Vita-More

Load video
YouTube

Transhumanist thinker Natasha Vita-More explores the idea of deliberately designing future human capabilities and bodies using emerging technologies. The presentation is a useful historical statement of technological transhumanism, although its envisioned future enhancements should be evaluated separately from established scientific evidence.

Body by Design: An Iteration for Life | Natasha Vita-More, TEDxMünchenSalon, 2014

Restoring Words: A Speech Neuroprosthesis | Edward Chang

Load video
YouTube

UCSF neurosurgeon Edward Chang, whose laboratory co-led the 2025 streaming brain-to-voice study, explains how his team built a neuroprosthesis that decodes attempted speech from cortical activity in people who have lost the ability to speak. The lecture, published by the UCSF Department of Medicine, walks through how recorded cortical signals are turned into words, illustrating the Neural Electricity and Signal Decoding section and the limits of what such systems actually read.

Restoring Words: Development of a Speech Neuroprosthesis for Communication with Edward Chang | UCSF Department of Medicine

Tailor-Made: The First Personalized Gene-Editing Treatment | CNBC

Load video
YouTube

This roughly 36-minute CNBC documentary follows KJ Muldoon, his family, and the Children's Hospital of Philadelphia and Penn Medicine team that designed, manufactured, and delivered a base-editing therapy for his CPS1 deficiency within months. It makes the Molecular Biology and Genome Editing section concrete and shows why a single successful case is both a breakthrough and a narrow piece of evidence.

Tailor-Made: The World's First Personalized Gene-Editing Treatment | CNBC Television

Mapping the Brain Synapse by Synapse | Jeff Lichtman

Load video
YouTube

In this 2022 public lecture for the Science and Cocktails series in Copenhagen, Harvard neuroscientist Jeff Lichtman, whose laboratory later published the cubic-millimeter map of human cortex with Google, explains connectomics and what synapse-level maps can and cannot reveal about how brains store information. It is the best companion to the Information, Memory, and Consciousness and Whole-Brain Emulation sections, because it conveys how enormous the data challenge of mapping a brain really is.

Mapping the Brain Synapse by Synapse to Explore the Mind with Jeff Lichtman | The Science and Cocktails Foundation, 2022

Neurorights: Human Rights Guidelines for Neurotechnology | Rafael Yuste

Load video
YouTube

Columbia University neuroscientist Rafael Yuste, a co-founder of the Neurorights Foundation, makes the case for human rights protections, such as mental privacy, personal identity, and free will, as neurotechnology and AI advance, in a talk hosted by Columbia's Institute for the Study of Human Rights. It provides background for the Cognitive Liberty and Neurorights section and for the national and international policies, such as UNESCO's 2025 recommendation, that followed.

Neurorights: Human Rights Guidelines for Neurotechnology and Artificial Intelligence | Institute for the Study of Human Rights

Additional Historical Viewing

The Coming Transhuman Era | Jason Sosa, TEDxGrandRapids, 2014

Jason Sosa presents an early popular account of technological convergence and human augmentation. The talk is shorter than the longer-form presentations above, but remains useful for understanding how transhumanist expectations were communicated before recent advances in neural interfaces and generative AI.

What Is Transhumanism? | Albert Lin, National Geographic Storytellers Summit, 2019

National Geographic Explorer Albert Lin discusses the personal impact of advanced prosthetics after the loss of his leg. His experiences illustrate the distinction between abstract predictions of superhuman abilities and the immediate practical value of restorative technology.

References and Further Reading

Philosophy and Transhumanist Thought

Neural Interfaces and Brain Science

Genetic Enhancement, Biological Repair, and Longevity

Digital Legacy and Posthumous Technology

Ethics and Governance

Conclusion

Transhumanism explores one of the most consequential possibilities in technological development: that human physical, cognitive, and biological capabilities may be increasingly shaped by deliberate engineering rather than biological evolution alone. Some aspects of this vision are already real. Advanced prosthetics restore movement and sensation, neural interfaces can recover selected communication abilities, genome editing can treat particular inherited diseases, and artificial intelligence provides increasingly powerful cognitive assistance; research from 2024 through 2026 has strengthened the evidence supporting several of these technologies.

However, the more radical ambitions of transhumanism remain unresolved. There is no demonstrated technology for transferring human consciousness into a computer, producing a complete functional copy of a human mind, or achieving biological immortality. AI-generated digital personalities can preserve and imitate aspects of individuals, but they are not evidence that those individuals continue to exist as conscious beings. The distinction between restoration, enhancement, simulation, and personal survival is essential.

The future importance of transhumanism will depend not only on advances in computing, biotechnology, and neuroscience, but also on whether these capabilities improve human health, agency, relationships, and well-being. The most important question is not simply how far technology can transform human beings. It is what those transformations will mean for the people experiencing them and for the societies in which they live.

Retrieved from "https://primo.ai/w/index.php?title=Transhumanism&oldid=52093"